Head and Neck Cancers Coverage From Every Angle

Published Medical Literature

Clinical Benefits of Cetuximab Versus Cisplatin in HPV-Positive Oropharyngeal Cancer
Durvalumab With or Without Tremelimumab in Subgroup of Resistant Head and Neck Cancer
Aggressive Thyroid Malignancies Tested for Somatostatin Receptors
High Rate of Suicide in Survivors of Head and Neck Cancer
Therapeutic Vaccine for HPV-Related Head and Neck Cancer
Comparing Cisplatin Dose Regimens in Treatment of Head and Neck Cancer
Combining Olaparib and Chemoradiotherapy in Heavy Smokers With Head and Neck Cancer
Comparing Surgical Approaches for Head and Neck Cutaneous Squamous Cell Carcinoma
How Do Radiotherapy and Surgery Compare in Oropharyngeal Cancer?
Managing Older Patients With Early Head and Neck Cancer: Foresee Morbidities, Minimize Toxicity
Does Following Induction Therapy With Cetuximab Radiotherapy Improve Outcomes in Head and Neck Cancers?
Male Sex as Predictor of Survival in Some Cases of Papillary Thyroid Cancer
Does Location of Nasoethmoidal Squamous Cell Carcinoma Affect Outcomes?
Further Evidence Links Diet and Risk of Head and Neck Cancer
Childhood Trauma and Risk for Emotional Disorders in Patients With Head and Neck Cancer
For Advanced Head and Neck Cancers, Prognostic Tools Emerge
Clinical Applications of in Vivo Optical Imaging in Head and Neck Cancer
Reconsidering Impact of Metastatic Node Number in Hypopharyngeal, Laryngeal Cancers
Papillary Versus Follicular Thyroid Carcinoma: Age May Impact Mortality
Disease-Relevant Signaling Pathways in Head and Neck Cancers
Combination Pazopanib Plus Cetuximab Therapy Warrants Further Study
Does Addition of Motolimod to Standard Chemotherapy Improve Outcomes in Head and Neck Cancer?
Can Response to Induction Chemotherapy Determine Radiation Doses in HPV+ Head/Neck Cancers?
Addition of Concurrent Chemotherapy to Chemoradiotherapy in Locally Advanced Head and Neck Cancers
Are Thyroid Cancer Survivors at Risk for Cardiovascular Disease?
Study Sheds Light on Dendritic Cell Subsets in Tonsillar Cancer
Can Phenotyping Lead to Better Treatments in Head and Neck Cancer?
Treating Nasopharyngeal Carcinoma With Nivolumab
Nedaplatin- Versus Cisplatin-Based Chemoradiotherapy for Nasopharyngeal Carcinoma
Predicting Outcomes in Recurrent Laryngeal Carcinoma With TILs
Should Low-Dose, Once-a-Week Adjuvant Cisplatin Be Standard of Care?
Is Radioiodine Treatment of Thyroid Cancer Linked to Risk of Hematologic Malignancies?
Is There a Link Between Depression and Survival in Patients With Head and Neck Cancer?
ASCO Clinical Practice Guideline Update: Larynx Preservation in the Treatment of Laryngeal Cancer
Addition of Erlotinib to First-Line Treatment of Head and Neck Cancers

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.